BioXcel Therapeutics (BTAI) said Friday it has regained compliance with Nasdaq's minimum closing bid price requirement.
The company said it received a written notice that it met on Wednesday the minimum closing bid price requirement of $1.00 per share for at least 12 straight trading days.
Shares of BioXcel were up more than 12% in recent trading.
Price: 1.94, Change: +0.21, Percent Change: +12.14
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.